全文获取类型
收费全文 | 4833篇 |
免费 | 435篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 194篇 |
妇产科学 | 59篇 |
基础医学 | 556篇 |
口腔科学 | 76篇 |
临床医学 | 521篇 |
内科学 | 935篇 |
皮肤病学 | 51篇 |
神经病学 | 331篇 |
特种医学 | 440篇 |
外科学 | 611篇 |
综合类 | 130篇 |
一般理论 | 3篇 |
预防医学 | 459篇 |
眼科学 | 135篇 |
药学 | 320篇 |
中国医学 | 10篇 |
肿瘤学 | 456篇 |
出版年
2022年 | 39篇 |
2021年 | 107篇 |
2020年 | 55篇 |
2019年 | 117篇 |
2018年 | 94篇 |
2017年 | 67篇 |
2016年 | 96篇 |
2015年 | 100篇 |
2014年 | 132篇 |
2013年 | 214篇 |
2012年 | 256篇 |
2011年 | 247篇 |
2010年 | 156篇 |
2009年 | 134篇 |
2008年 | 222篇 |
2007年 | 230篇 |
2006年 | 246篇 |
2005年 | 229篇 |
2004年 | 225篇 |
2003年 | 221篇 |
2002年 | 169篇 |
2001年 | 182篇 |
2000年 | 143篇 |
1999年 | 115篇 |
1998年 | 72篇 |
1997年 | 57篇 |
1996年 | 54篇 |
1995年 | 47篇 |
1994年 | 52篇 |
1993年 | 52篇 |
1992年 | 66篇 |
1991年 | 66篇 |
1990年 | 56篇 |
1989年 | 74篇 |
1988年 | 65篇 |
1987年 | 84篇 |
1986年 | 50篇 |
1985年 | 61篇 |
1984年 | 51篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1981年 | 36篇 |
1980年 | 37篇 |
1979年 | 25篇 |
1978年 | 38篇 |
1977年 | 39篇 |
1976年 | 31篇 |
1975年 | 31篇 |
1974年 | 29篇 |
1972年 | 32篇 |
排序方式: 共有5301条查询结果,搜索用时 171 毫秒
51.
52.
Tang NL Hui J Law LK Lam YY Chan KY Yeung WL Chan AY Cheung KL Fok TF 《Human mutation》2000,16(5):446
Glutaric acidemia type I is caused by mutations of the glutaryl-CoA dehydrogenase (GCDH) gene resulting in loss of GCDH enzyme activity. Patients present with progressive dystonia and lesions in basal ganglia. Dietary treatment, when instituted from the early neonatal period, markedly reduces dystonia and morbidity. Early diagnosis and prenatal diagnosis will be facilitated by knowledge of locally prevalent GCDH mutations. Several common GCDH mutations have been found in different ethnic groups. GCDH mutations were studied in 5 Chinese glutaric acidemia type I families. We detected two novel recurrent mutations (A219T and IVS10-2A>C) which were found in two unrelated families. An asymptomatic carrier of IVS10-2A>C was also found on screening of 120 individuals. Other mutations were identified, including two other novel (R386G & IVS3+1G>A) and two known mutations (G178R & R355H). Fibroblasts from patients carrying the novel mutations were confirmed to be deficient for GCDH activity. This is the first report of GCDH mutations describing recurrent mutations in Chinese patients. The carrier rate of IVS10-2A>C may be particularly high in Chinese. 相似文献
53.
Mutations in the SLC22A5 gene, which encodes for the plasma membrane carnitine transporter OCTN2, cause primary carnitine deficiency (PCD). After our first report of OCTN2 mutations in Chinese, three more Chinese PCD patients were identified. The parents of these families were non-consanguineous and these families were unrelated. Two novel truncating mutations were found: R254X, a single-base mutation at cDNA position 981 (c.981C>T); and Y387X (c.1382T>G). Two probands, one each from Taiwan and Macau, were homozygous for R254X. The other proband from Taiwan carried both R254X and Y387X. Two additional heterozygote carriers of R254X were also identified among 250 control samples, while none was detected for Y387X. The population carrier rate for R254X would be about 1 in 125. Haplotypes of R254X alleles were examined and patients homozygous for R254X were also homozygous for the same haplotype of intragenic and microsatellites markers. Analysis of population frequencies of haplotypes revealed that the chance of 4 chromosomes having arisen as independent events was 0.016. We conclude that R254X is probably a founder mutation in Chinese. Other previously reported mutations found in the Japanese population were also screening in 250 control samples but no carrier was identified, indicating that they were either very rare or not present in Southern Chinese. 相似文献
54.
55.
DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The nucleotide sequences of the PorB proteins from 28 nonserotypeable serogroup C ET-15 meningococci recovered from invasive meningococcal disease cases were determined. PCR amplification of the porB genes responsible for encoding the serotype antigen was used for DNA sequence determination and identification of the nature of the serotype antigen. DNA sequencing revealed that three strains were of serotype 2a, and of the remaining 25 strains, 20 were found to have an identical single point mutation in the region of the VR3 gene, which encodes surface-exposed loop VI, where the serotype 2a epitope resides. This nonsynonymous mutation was confirmed by synthetic peptide immunochemical analysis to confer new serospecificity to these serotype 2a mutants. This finding of a potential novel mutational hot spot on the PorB proteins of meningococci may have implications for pathogenesis and vaccine development. 相似文献
56.
The demonstration of hepatitis B antigen in the liver cells in formalin fixed paraffin embedded tissues by Shikata's orcein staining method affords an opportunity to conduct retrospective studies on necrospy materials. Such a study in Singapore showed orcein-positive liver cells in 22 out of 52 (42.3%) and 37 out of 50 (74.0%) cases of cirrhosis of the liver and hepatocellular carcinoma respectively, while only 5 out of 113 (4.4%) 'normal' livers gave positive results. There is a significant difference in the frequency of hepatocellular carcinoma in orcein-positive and orcein-negative cirrhotic livers (28 out of 50, 10 out of 40 respectively). These results suggest a possible aetiological relationship between hepatitis B antigen and hepatocellular carcinoma. 相似文献
57.
58.
59.
60.
Hauff K Zamzow C Law WJ De Melo J Kennedy K Los M 《Archivum immunologiae et therapiae experimentalis》2005,53(4):308-320
In this review we focus on peptide- and peptidomimetic-based approaches that target autoimmune diseases and some pathologies of the central nervous system. Special attention is given to asthma, allergic rhinitis, osteoarthritis, and Alzheimer's disease, but other related pathologies are also reviewed, although to a lesser degree. Among others, drugs like Diacerhein and its active form Rhein, Pralnacasan, Anakinra (Kineret), Omalizumab, an antibody "BION-1", directed against the common beta-chain of cytokine receptors, are described below as well as attempts to target beta-amyloid peptide aggregation. Parts of the review are also dedicated to targeting of pathologic conditions in the brain and in other tissues with peptides as well as methods to deliver larger molecules through the "blood--brain barrier" by exploring receptor-mediated transport, or elsewhere in the body by using peptides as carriers through cellular membranes. In addition to highlighting current developments in the field, we also propose, for future drug targets, the components of the inflammasome protein complex, which is believed to initiate the activation of caspase- 1 dependent signaling events, as well as other pathways that signal inflammation. Thus we discuss the possibility of targeting inflammasome components for negative or positive modulation of an inflammatory response. 相似文献